Arginine is a second messenger-like molecule that reprograms metabolism to promote tumor growth. Cell #Phenomics #HepatocellularCarcinoma #metabolism cell.com/cell/fulltext/…
🔥MORPHEUS-Phase Ib/II Liver study: Tiragolumab in combination with AtezoBev in #hepatocellularcarcinoma #ASCO23
👉Interesting signal of activity for anti-TIGIT 💊in #HCC (despite control arm 🤨), looking forward to IMbrave152/ SKYSCRAPER-14
ESMO - Eur. Oncology OncoAlert EASL Education EASL Education…
🎙️SBRT showed ⬆️local antitumoral activity for #HCC than TACE-DEB, w/o detrimental effects on OS, tox & QoL‼️ OncoAlert IJROBP - The Red Journal
📌Ph3 RCT: TACE-DEB ✖️ SBRT treatments for #hepatocellularcarcinoma (HCC)
TACE-DEB : Max 4 procedures; ablation allowed after incomplete TACE-DEB…
#tb to 2022 ⬅️
Study Protocol: Adjuvant Holmium-166 #Radioembolization After #RadiofrequencyAblation in Early-Stage #HepatocellularCarcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
link.springer.com/article/10.100…
#OpenAccess 🔓
That was indeed a wonderful talk by Rhea Pai at Telethon Kids Institute about her PhD work! Thanks for letting us know more about oncofetal reprogramming of tumor ecosystem!!
#hepatocellularcarcinoma #oncofetal #reprogramming
January's Editor's Essential Reading evaluates regional differences in clinical presentation and prognosis of patients with post–sustained virologic response #hepatocellularcarcinoma . Click the link to check out the full article 🔗ow.ly/5Wze50QkOTa
🔥Pembrolizumab vs plc as 2nd Line in #HepatocellularCarcinoma
Journal of Clinical Oncology
doi.org/10.1200/JCO.22…
✅Asian phs-III KEYNOTE-394
👉ORR: 12.7 vs 1.3%
👉mPFS: 2.6 vs 2.3 mo
👉moS: 14.6 vs 13.0 mo
🧐In line with KN-224& 240-> efficacy in a subgroup
ESMO - Eur. Oncology EASL Education #livertwitter
🔥Nivolumab + Cabozantinib With or Without Ipilimumab for #hepatocellularcarcinoma
Journal of Clinical Oncology
doi.org/10.1200/JCO.22…
✅cohort 6 CM-040
👉ORR 17 vs 29%
👉mPFS 5.1 vs 4.3 mo
👉mOS 20.2 vs 22.1 mo
🧐Activity, but triplet not yet convincing
ESMO - Eur. Oncology EASL Education #LiverTwitter
American Liver Foundation's Corporate Council Meeting September 12th, 2023! Ali Zarrinpar American Liver Foundation National #liverhealth #liverdisease #livertumor #livertransplant #hcv #hepc #hepatocellularcarcinoma #hepatitis #cirrhosis
🥳Joint Special Issue 'Clinical Management of Liver Cancers' in JCM MDPI and Livers are online
mdpi.com/journal/jcm/sp…
mdpi.com/journal/livers…
Guest Editors: Dr. Kumar Jayant and Dr. Isabella Reccia, from Imperial College London
#livercarcinoma #livercancers #hepatocellularcarcinoma
HOPE for the Week: The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation.
#HOPEForTheWeek #HepatocellularCarcinoma
onlinelibrary.wiley.com/doi/10.1111/ao…
#AdvancedGlycationEndproduct (AGE)⏫liver matrix #Viscoelasticity (Collagen bundle network with shorter fibers & smaller angles), but not #Stiffness
#T2DM #NASH #MASH
A mechanosensitive integrin β1–Tensin 1– #YAP cascade (⏫by high Viscoelasticity) ⏫ #HepatoCellularCarcinoma …
药物名称： #PHOREGO
通用名称： #瑞戈非尼
药品类别：肿瘤
适用疾病： 1. 结直肠癌（ #CRC ）
2.胃肠道间质瘤（ #GIST ）
3.肝细胞癌（ #HCC ）
#colorectalcancer
#Gastrointestinalstromaltumor
#Hepatocellularcarcinoma #化药药 #杰拉 #气向药 #genericdrug #targeteddrug #Regorafenib #Bangladesh
#Cabozantib #caboxib #xl184 #cabozantinib80mg #cometriq #cabozanix #HepatocellularCarcinoma (HCC) #hyroidcancer (DTC) #RenalCellCarcinoma (RCC) #TargetedTherapy
WeChat : drug-international / lifesaving-medicine website : medicine-international.com
🆕Expert Opinion❕
Immunotherapy & Transplantation for #HepatocellularCarcinoma
Read it here👉journal-of-hepatology.eu/article/S0168-…
#LiverTwitter
#TACE + #Durvalumab + #Bevacizumab demonstrates superior PFS (23% reduced risk) when compared to #TACE alone for the treatment of #hepatocellularcarcinoma .
Congratulations to the #Emerald1 investigators. Welcome the #combinationtherapy era.🧩
astrazeneca.com/media-centre/p…
🆕Article in press❕
Characteristics and outcomes of immunotherapy-related #liverinjury in patients with #hepatocellularcarcinoma versus other advanced solid tumours
🔓 #OpenAccess at👉journal-of-hepatology.eu/article/S0168-…
#LiverTwitter
1/7 📢 NEW from JVIR: An interesting study on the use of ablative dose Yttrium-90 radioembolization for large hepatocellular carcinoma (HCC) ≥ 5 cm.
Let's delve into the details! 🔍🔬
#Radioembolization #HepatocellularCarcinoma #HCC Society of Interventional Radiology SIO
